Filing Details

Accession Number:
0001104659-22-124566
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-05 16:13:38
Reporting Period:
2022-12-05
Accepted Time:
2022-12-05 16:13:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1390478 Sellas Life Sciences Group Inc. SLS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568734 Thomas John Burns C/O Sellas Life Sciences Group, Inc.,
7 Times Square, Suite 2503
New York NY 10036
Senior Vp, Finance & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2022-12-05 1,159 $2.59 29,347 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.